Advertisement.

OTIC Projected Dividend Yield

Otonomy Inc ( OTCBB : OTIC )

Otonomy is a biopharmaceutical company focused on the development of innovative therapeutics for neurotology. Co. developed the application of drug delivery technology to the ear. Co.'s primary focus is on the development of three programs in its pipeline: OTO-313 in Phase 2 for tinnitus; OTO-413 in Phase 2a for hearing loss; and OTO-825, a gene therapy for congenital hearing loss, in investigational new drug (IND)-enabling activities. Additionally, Co. is conducting preclinical development of OTO-510 for otoprotection and OTO-6XX for severe hearing loss.

11 YEAR PERFORMANCE RESULTS

OTIC Dividend History Detail
OTIC Dividend News
OTIC Competitors News

# of Shares: 0

Closing Price: 0.01

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.11
Dividend 1 Yr Growth = ( 0.00 – 0.11 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.11

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2023	N/A	Apr 11, 2023	Mar 28, 2023	Apr 10, 2023	0.1100
2023 Total:					0.1100